Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinoma.
BACKGROUND: To explore the association between serum human epidermal growth factor receptor 2 (HER 2) extracellular domain (ECD) levels and tissue HER 2 status in metastatic gastric cancer. PATIENTS AND METHODS: HER 2 status was retrospectively analyzed in 219 advanced gastric or gastroesophageal ju...
Main Authors: | Shu-Qin Dai, Xin An, Fang Wang, Qiong Shao, Yong-Chang Chen, Ya-Nan Kong, Cui Chen, Cong Li, Hui-Yan Luo, Ying Liang, Feng-Hua Wang, Rui-Hua Xu, Yu-Hong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3653938?pdf=render |
Similar Items
-
Trastuzumab for the treatment of HER2- positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
by: G Norman, et al.
Published: (2011-05-01) -
HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas
by: Indu Rajagopal, et al.
Published: (2015-03-01) -
Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
by: Kate Young, et al.
Published: (2015-11-01) -
Controversies of Gastro-oesophageal Junction and “Gastric cardia” and the role of Gastro-oesophageal reflux in it
by: S. Wijetunge
Published: (2022-08-01) -
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
by: Irene Gullo, et al.
Published: (2015-02-01)